Hepatoid Adenocarcinoma of the Lung with EGFR Mutation and the Response to Tyrosine Kinase Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatoid Adenocarcinoma of the Lung with EGFR Mutation and the Response to Tyrosine Kinase Inhibitors

Published:2019-10 Issue:10 Volume:14 Page:e217-e219
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Chen Hua-fei,Wang Wen-xian,Li Xing-liang,Xu Chun-wei,Du Kai-qi,Zhu You-cai,Fang Mei-yu

Funder

Science and Technology Planning project of Zhejiang Province

Medical Scientific Research Foundation of Zhejiang Province of China

Technology Bureau of Jiaxing City of Zhejiang Province

Xisike-Hanson Cancer Research Foundation

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference5 articles.

1. Hepatoid adenocarcinoma of the lung: review of a rare form of lung cancer;Grossman;Respir Med,2016

2. Epidermal growth factor receptor (EGFR) kinase inhibitors and non-small cell lung cancer (NSCLC)-advances in molecular diagnostic techniques to facilitate targeted therapy;Ghafoor;Pathol Oncol Res,2018

3. The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer;Zhao;Sci Rep,2017

4. Review on EGFR inhibitors: critical updates;Singh;Mini Rev Med Chem,2016

5. Hepatoid adenocarcinoma - review of the literature illustrated by a rare case originating in the peritoneal cavity;Metzgeroth;Onkologie,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis;BMC Cancer;2024-08-02

2. A case of hepatoid adenocarcinoma of the lung harboring KRAS G12C responded favorably to sotorasib;Pathology International;2024-07-17

3. Long survival after neoadjuvant and adjuvant camrelizumab plus chemotherapy and surgery in a patient with hepatoid adenocarcinoma of the lung: A case report;Human Vaccines & Immunotherapeutics;2024-04-24

4. Hepatoid adenocarcinoma of the lung with PD-L1 expression and the response to anti-PD-1 therapy: a case report;Frontiers in Oncology;2023-11-23

5. A 47-year-old female with primary hepatoid adenocarcinoma in the pelvic retroperitoneum;Quantitative Imaging in Medicine and Surgery;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3